Company Description
ETHZilla Corporation operates as a technology company in the decentralized finance industry.
It connects financial institutions, businesses and organizations worldwide by enabling secure, accessible blockchain transactions through Ethereum Network protocol implementations.
The company, through its proprietary protocol implementations, facilitates DeFi transactions and asset digitization across multiple Layer 2 Ethereum networks.
The Company offers tokenization solutions, DeFi protocol integration, blockchain analytics, traditional-to-digital asset conversion gateways, and other decentralized finance services.
The company was formerly known as 180 Life Sciences Corp. and changed its name to ETHZilla Corporation in August 2025.
ETHZilla Corporation is headquartered in Palm Beach, Florida.
| Country | United States |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 4 |
| CEO | McAndrew Rudisill |
Contact Details
Address: 2875 South Ocean Blvd, Suite 200 Palm Beach, Florida 33480 United States | |
| Phone | 650 507 0669 |
| Website | ethzilla.com |
Stock Details
| Ticker Symbol | ETHZ |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001690080 |
| CUSIP Number | 68236V401 |
| ISIN Number | US68236V4014 |
Key Executives
| Name | Position |
|---|---|
| McAndrew Rudisill BA(Econ) | Executive Chairman and Chief Executive Officer |
| John T. Saunders | Senior Vice President and Chief Financial Officer |
| Eric R. Van Lent | Chief Accounting Officer and Secretary |
| John D. Kristoff | Senior Vice President of Corporate Communications and Investor Relations |